Kolexia
Sibertin-Blanc Camille
Gastro-entérologie
Centre Hospitalier Toulon
Toulon, France
36 Activités
1 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du foie Tumeurs de l'estomac Pneumopathie infectieuse Hypertension artérielle Ictère rétentionnel Hypersensibilité Tumeurs neuroendocrines Métastase tumorale

Industries

Servier
4 collaboration(s)
Dernière en 2021
Boston Scientific
3 collaboration(s)
Dernière en 2023
Merck-Serono
1 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2020

Dernières activités

POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Impact on the Nutritional State and the Quality of Life: Conformity With European Recommendations Concerning the Nutritional Care of the Cancerous Patients Benefiting From a Treatment by Chemotherapy Impact on the Nutritional State and the Quality of Life
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   09 mars 2023
Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
Therapeutic advances in medical oncology   26 décembre 2022
Gastric tumors.
La Revue du praticien   20 mai 2019
Clinical outcome after biliary drainage for metastatic colorectal cancer: Survival analysis and prognostic factors.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   21 septembre 2017
Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study.
Health and quality of life outcomes   27 avril 2017
Impact of genetic polymorphisms of VEGF pathway on the response to bevacizumab in metastatic colorectal cancer (mCRC): Ancillary study of PRODIGE 9 trial.
2016 ASCO Annual Meeting I   20 mai 2016
Monoclonal antibodies for treating gastric cancer: promises and pitfalls.
Expert opinion on biological therapy   25 mars 2016
Chimiothérapie de première ligne dans les cancers du pancréas métastatiques : où en sommes-nous ?
Edimark   15 avril 2015
Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   30 décembre 2014